Effects of kappa receptor agonists on D1 and D2 dopamine agonist and antagonist-induced behaviors

Psychopharmacology

Volumn 123, Issue 2, 1996, Pages 215-221

  Marin, Conepció ^a,b   Engber, Thomas M ^a   Chaudhuri, Pia ^a   Peppe, Antonella ^a   Chase, Thomas N ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Catalepsy; Dopamine; Grooming; Kappa opioids; Spiradoline; Stereotypies

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DYNORPHIN; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; NALOXONE; NORBINALTORPHIMINE; OPIATE ANTAGONIST; QUINPIROLE; RACLOPRIDE; SPIRADOLINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CATALEPSY; CONTROLLED STUDY; CORPUS STRIATUM; DRUG ANTAGONISM; DRUG POTENTIATION; DRUG SELECTIVITY; ENTOPEDUNCULAR NUCLEUS; GROOMING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOTYPY; SUBCUTANEOUS DRUG ADMINISTRATION; SUBSTANTIA NIGRA;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; 3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; BEHAVIOR, ANIMAL; CATALEPSY; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA;

EID: 0030054015     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02246181     Document Type: Article

References (45)

1. Alheid GF, Heimer L (1988) New perspectives in basal forebrain organization of especial relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid and corticopetal components of the substantial innominata. Neuroscience 27; 1-39
2. 3H] SCH23390 in spinal cord and discrete brain regions of kappa-opiate. 1. Tolerant dependent and abstinent rats. Pharmacology 42:121
3. Biggio G, Casu M, Corda MG, Di Bello C, Cessa GL (1978) Stimulation of dopamine synthesis in caudate nucleus by intrastriatal enkephalins and antagonism by naloxone. Science 200: 552-554
4. 2 receptor interaction in the generation of dopamine agonist related behaviors. Eur J Pharmacol 131:301-306
5. Chavkin C, James IF, Goldstein A (1982) Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 215: 413-415
6. 1 antagonist SCH23390 in comparison with neuroleptic. Life Sci 34: 1529-1540
7. Collingridge GL, Davies J (1982) Actions of substance P and opiates in the rat substantia nigra. Neuropharmacology 21:715-719
8. Creese I, Chen A (1985) Selective D, dopamine receptor increase following chronic treatment with SCM23390. Eur J Pharmacol 109:127-128
9. De Ryck M, Teitelbaum P (1983) Morphine versus haloperidol catalepsy in the rat: an electromyographic analysis of postural support mechanisms. Exp Neurol 79:54-76
10. Di Chiara G, Imperato A (1988) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244:1067-1080
11. Eghbali M, Santoro C, Paredes W, Gardner EL, Zukin RS (1987) Visualization of multiple opioid receptor types in rat striata after specific mesencephalic lesions. Proc Natl Acad Sci USA 84: 6582-6586
12. 2 agonists. Eur J Pharmacol 200:171-173
13. 2 receptor stimulation on somatostatin, neuropeptide y, neurotensin, dynorphin and enkephalin. Brain Res 581:261-268
14. Ernst AM (1967) Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharmacologia 10:316-323
15. Gerfen CR, Young III WS (1988) Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res 460:161-167
16. 2 DA receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250:1429-1432
17. 1 dopamine receptors for the jerks induced by B-HT 920 in rats. J Pharm Pharmacol 29:660-661
18. Graybiel A (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 13:244-254
19. Hommer D, Pert A (1983) The actions of opiates in the rat substantia nigra: an electrophysiological analysis. Peptides 4: 603-608
20. 2 receptor blockade have additive cataleptic effects in mice, but receptor effects may interact in opposite ways. Pharmacol Biochom Behav 29:223-229
21. LeMoine C, Normand B, Guitteny AF, Fonque B, Teoule R, Bloch B (1990) DA receptor gene expression by enkephalin neurons in rat forebrain. Proc Natl Acad Sci USA 87:230-234
22. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ (1987) Autoradiographic differentiation of mu, delta and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci 7: 2445-2464
23. Matsumoto RR, Brinsfield KH, Patrick RL, Walker JM (1988) Rotational behavior mediated by dopaminergic and nondopaminergic mechanisms after intranigral microinjection of specific mu, delta and kappa opioid agonists. J Pharmacol Exp Ther 246:196-203
24. 2 agonists LY171555 and RU24213. Life Sci 42: 2561-2567
25. 1 antagonist SCH23390. Psychopharmacology 82:409-410
26. 1 agonist SKF38393 and its R and S-enantiomers in the intact adult rats. Psychopharmacology 92:164-168
27. Mulder AH, Wardeh G, Hogenboom F, Frankhuyzen AL (1984) κ- and δ-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release. Nature 308:278-280
28. 2 agonist LY163502. Psychopharmacology 98:245-250
29. 2 receptor-mediated function: behavioural indices. Eur J Pharmacol 186:79-86
30. Murrin LC, Coyle JT, Kuhar MJ (1980) Striatal opiate receptor: pre and postsynaptic localization. Life Sci 27:1175-1183
31. Parashos SA, Barone P, Marin C, Paraschos SA, Kapitzoglou-Logothetis V, Chase TN (1989a) Haloperidol- and SCH23390-induced dopaminergic supersensitivities are not additive in the rat. Psychopharmacology 98:189-192
32. 2 antagonists in the induction of catalepsy. Neurosci Lett 105:169-173
33. 2 dopamine antagonists on SKF38393-induced non-stereotyped grooming in rats. Psychopharmacology 102: 411-413
34. Pickel VN, Sumal KK, Beckley SC, Miller RJ, Reis DJ (1980) Immunocytochemical localization of enkephalin in the neostriatum of the rat brain: a light and microscopic study. J Comp Neurol 189:721-740
35. Pollard H, Llorens-Cortes C, Schwartz JC (1977) Enkephalin receptors on dopaminergic neurons in rat striatum. Nature 268: 745-747
36. 1 dopamine receptors, Eur J Pharmacol 118:367-370
37. 5-enkephalin. Psychopharmacology 343:458-462
38. Sasame HA, Perez Cruet J, Di Chiara G, Tagliamonte A, Tagliamonte P, Gessa GL (1972) Evidence that methadone blocks dopamine receptors in the brain. J Neurochem 19: 1953-1957
39. Thompson LA, Walker JM (1990) Inhibitory effects of the k opiate U50,488 in the substantia nigra pars reticulata. Brain Res 517:81-87
40. 2 receptors of the rat. Fur J Pharmacol 235:23-30
41. Vincent SR, Hökfelt T, Christensson, Terenius L (1982) Immunohistochemical evidence for a dynorphin immunoreactive striatonigral pathway. Eur J Pharmacol 85:251-252
42. Waddington JL, Molloy AG, O'Boyle KM, Mashurano M (1986) Motor consequences of D, dopamine receptor stimulation and blockade. Clin Neuropharmacol 9 [Suppl. 4]:20-22
43. Walker JM, Friederick MW (1985) Electrophysiological and behavioral actions of dynorphin in the substantia nigra. Neurosci Abstr 11:1163
44. Walker JM, Thompson LA, Frascella J, Friederick MW (1987) Opposite actions of mu and kappa opiates on the firing of dopamine cells in the rat substantia nigra. Eur J Pharmacol 134: 53-59
45. Wolgin IDL (1985) Forelimb placing and hopping reflexes in haloperidol and morphine-treated cataleptic rats. Behav Neurosci 99:423-435